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Background: Impaired left ventricular ejection fraction (LVEF) predicts increased hospital mortality in patients undergoing percutaneous coronary 
intervention (PCI). However, the impact on longer-term survival and the relationship of this to hospital outcome remain unclear. We set out to clarify 
this in a large, single-centre cohort.
Methods: Consecutive patients undergoing PCI at a London Tertiary Referral Centre were screened for inclusion. LVEF was categorized as Good 
(EF≥50%), Moderate (31-49%) or Poor (≤30%) at the time of revascularization. Demographic, procedural and outcome details were assessed by 
univariate and multivariate analyses. Data are mean ±SD.
Results: 2356 patients were eligible for study (age 65+11.1yrs). 43% presented as acute coronary syndromes. LVEF was a strong predictor of 
mortality on univariate and multiple regression analyses (30-day HR 2.47 (95% CI 1.40-4.34) and 2.1 years HR 1.99 (95% CI 1.46-2.67). 30-day 
mortality rates post-PCI were 0.5%, 2.1% and 8.8% for patients with good, moderate and poor LVEF, respectively (p<0.001), representing 14.7%, 
32.3% and 57.5% of all deaths in each category at a mean follow-up of 2.1+1.4 years (p<0.001) (Figure 1).
Conclusion: LVEF is a strong predictor of early and late outcome after PCI, with an inverse correlation between extent of impairment and time-
course for all-cause mortality. Strategies to address this at the time of intervention (eg IABP therapy) may have a beneficial effect on outcomes in 
this patient group.
